Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19001955 | 0.95 | PDK2 (0.32) | PDK2PLA2G2APLA2G4AMEN1THRB | |
| SCHEMBL19001767 | 0.94 | PLA2G2A (0.33) | PDK2PLA2G2APLA2G4A | |
| SCHEMBL19001763 | 0.94 | MMP12 (0.33) | PDK2AHRPLA2G2APLA2G4AMEN1 | |
| SCHEMBL23222590 | 0.94 | MMP12 (0.32) | PDK2 | |
| SCHEMBL19167299 | 0.93 | AHR (0.32) | AHRPLA2G2APLA2G4AMEN1KMT2A | |
| SCHEMBL15213958 | 0.93 | AHR (0.32) | AHRPLA2G2APLA2G4AMEN1KMT2A | |
| SCHEMBL19167384 | 0.93 | AHR (0.32) | AHRPLA2G2APLA2G4AMEN1THRB | |
| SCHEMBL19010993 | 0.93 | AHR (0.32) | AHRPLA2G2APLA2G4AMEN1THRB | |
| SCHEMBL15213678 | 0.93 | AHR (0.32) | AHRPLA2G2APLA2G4AMEN1THRB | |
| SCHEMBL23278403 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10381576-B2 | Electronic device having an amine containing layer processed from solution | MERCK PATENT GMBH (DE) | 2019-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10381576-B2 | Electronic device having an amine containing layer processed from solution | OCIAD1, OCIAD2, AOC2 | PDK2 1331/4885AHR 3573/4885PLA2G2A 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.